James J. Burns & Company’s iShares Biotechnology ETF IBB Stock Holding History

James J. Burns & Company’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,361	Closed	-$299K	–	161
2025 Q2	$299K	Sell	2,361 -421	-15%	-$51.7K	0.05%	126
2025 Q1	$356K	Buy	2,782 +421	+18%	+$57.1K	0.06%	104
2024 Q4	$311K	Buy	2,361 +310	+15%	+$43.6K	0.05%	111
2024 Q3	$298K	Buy	2,051 +347	+20%	+$50.2K	0.05%	111
2024 Q2	$234K	Buy	+1,704	New	+$227K	0.05%	116
2023 Q2	–	Sell	-2,059	Closed	-$266K	–	117
2023 Q1	$266K	Buy	+2,059	New	+$270K	0.07%	98

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

James J. Burns & Company's IBB Position: Q3 2025 in Review

James J. Burns & Company sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 2,361 shares — an estimated $299K sold.

James J. Burns & Company first reported a position in IBB in Q1 2023 and held it in 6 quarters. The position peaked at $356K in Q1 2025. 804 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

James J. Burns & Company reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
James J. Burns & Company sold 2,361 iShares Biotechnology ETF shares in Q3 2025, an estimated $299K.
James J. Burns & Company first reported a position in iShares Biotechnology ETF in Q1 2023 and held it in 6 quarters.
James J. Burns & Company's iShares Biotechnology ETF position peaked at $356K in Q1 2025.
804 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on James J. Burns & Company's 13F filing for Q3 2025, filed 20 Oct 2025.